drugset / Trial / NCT03072511
Smoking Cessation Intervention
Phase 4
Terminated
23 enrolled
University of Florida
National Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
Cigarette smoking is the leading cause of preventable mortality in the United States, yet less than 10% of smokers making a serious quit attempt remain abstinent from cigarettes 1 year later, and outcomes from gold-standard behavioral interventions leave much room for improvement. As such, in the context of a Stage-I randomized controlled trial (RCT), this study will examine (1) treatment characteristics and delivery, treatment integrity, dropout, and acceptability, (2) smoking outcomes such as lapse, relapse, and abstinence measures, and (3) changes decision-making that result from a novel intervention informed by behavioral analysis and social cognition.
Timeline
- Start
- 2016-12-13
- Primary completion
- 2018-08-01
- Completion
- 2018-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Nicotine | Unknown | 21 mg | Other |
Indications
No indication recorded.